Showing 1 - 16 results of 16 for search 'K. P. Anbalagan', query time: 0.32s Refine Results
  1. 1
    Medium effects on the reduction of kinetics of trans-dichloro-bis (1,2-diaminopropane) cobalt(III) by hexacyanoferrate(II) in aqueous organic solvents

    Medium effects on the reduction of kinetics of trans-dichloro-bis (1,2-diaminopropane) cobalt(III) by hexacyanoferrate(II) in aqueous organic solvents by K.P. Elango, K. Anbalagan, G. Karthikeyan

    Published 1998-06-01
    Get full text
    Article
  2. 2
    cis-Diaquatetrakis(1-butyl-1H-imidazole-κN3)nickel(II) dichloride

    cis-Diaquatetrakis(1-butyl-1H-imidazole-κN3)nickel(II) dichloride by P. S. Kannan, A. S. Ganeshraja, K. Rajkumar, K. Anbalagan, A. SubbiahPandi

    Published 2013-09-01
    Get full text
    Article
  3. 3
    Chloridobis(ethane-1,2-diamine)(4-methylaniline)cobalt(III) dichloride monohydrate

    Chloridobis(ethane-1,2-diamine)(4-methylaniline)cobalt(III) dichloride monohydrate by K. Ravichandran, P. Ramesh, C. Maharaja Mahalakshmi, K. Anbalagan, M. N. Ponnuswamy

    Published 2009-11-01
    Get full text
    Article
  4. 4
    Diaquadichloridobis(pyridine-κN)cobalt(II)

    Diaquadichloridobis(pyridine-κN)cobalt(II) by P.S. Kannan, A. S. Ganeshraja, K. Anbalagan, E. Govindan, A. SubbiahPandi

    Published 2013-09-01
    Get full text
    Article
  5. 5
    cis-Bromidobis(ethylene-1,2-diamine)(2-methylpropan-1-amine)cobalt(III) dibromide

    cis-Bromidobis(ethylene-1,2-diamine)(2-methylpropan-1-amine)cobalt(III) dibromide by M. Manjunathan, K. Anbalagan, K. Sambathkumar, E. Govindan

    Published 2018-09-01
    Get full text
    Article
  6. 6
    cis-Bromidobis(ethylene-1,2-diamine)(methylamine)cobalt(III) dibromide

    cis-Bromidobis(ethylene-1,2-diamine)(methylamine)cobalt(III) dibromide by S. Manimaran, E. Govindan, M. Manjunathan, K. Sambathkumar, K. Anbalagan

    Published 2018-06-01
    Get full text
    Article
  7. 7
    cis-Bromido(n-butylamine-κN)bis(ethene-1,2-diamine-κ2N,N′)cobalt(III) dibromide

    cis-Bromido(n-butylamine-κN)bis(ethene-1,2-diamine-κ2N,N′)cobalt(III) dibromide by M. Manjunathan, S. Manimaran, K. Anbalagan, K. Sambathkumar, E. Govindan

    Published 2018-07-01
    Get full text
    Article
  8. 8
    Enhancement of thermoelectric power factor of hydrothermally synthesised SrTiO3 nanostructures

    Enhancement of thermoelectric power factor of hydrothermally synthesised SrTiO3 nanostructures by N Yalini Devi, P Rajasekaran, K Vijayakumar, A S Alagar Nedunchezhian, D Sidharth, G Anbalagan, M Arivanandhan, R Jayavel

    Published 2020-01-01
    Get full text
    Article
  9. 9
    A Non-Invasive IR Sensor Technique to Differentiate Parkinson’s Disease from Other Neurological Disorders Using Autonomic Dysfunction as Diagnostic Criterion

    A Non-Invasive IR Sensor Technique to Differentiate Parkinson’s Disease from Other Neurological Disorders Using Autonomic Dysfunction as Diagnostic Criterion by Brindha Anbalagan, Sunitha Karnam Anantha, Sridhar P. Arjunan, Venkatraman Balasubramanian, Menaka Murugesan, Kalpana R

    Published 2021-12-01
    Get full text
    Article
  10. 10
    A novel method for autophagy detection in primary cells: impaired levels of macroautophagy in immunosenescent T cells.

    A novel method for autophagy detection in primary cells: impaired levels of macroautophagy in immunosenescent T cells. by Phadwal, K, Alegre-Abarrategui, J, Watson, A, Pike, L, Anbalagan, S, Hammond, E, Wade-Martins, R, McMichael, A, Klenerman, P, Simon, A

    Published 2012
    Journal article
  11. 11
    Comparison of Real-time RT-PCR cycle threshold (Ct) values with clinical features and severity of COVID-19 disease among hospitalized patients in the first and second waves of COVID-19 pandemic in Chennai, India

    Comparison of Real-time RT-PCR cycle threshold (Ct) values with clinical features and severity of COVID-19 disease among hospitalized patients in the first and second waves of COVI... by Sudhakar Natarajan, Mohan Ranganathan, P L Natarajan, Manohar Nesakumar, S Anbalagan, K Lucia Precilla, H Hemalatha, M Kannan, G Narendran, S Mahalakshmi, Gomathi Karmegam, Lakshmi Prakash, K Narayanasamy, Luke Elizabeth Hanna

    Published 2023-06-01
    Get full text
    Article
  12. 12
    Human adipose tissue-derived stromal/stem cells promote migration and early metastasis of triple negative breast cancer xenografts.

    Human adipose tissue-derived stromal/stem cells promote migration and early metastasis of triple negative breast cancer xenografts. by Brian G Rowan, Jeffrey M Gimble, Mei Sheng, Muralidharan Anbalagan, Ryan K Jones, Trivia P Frazier, Majdouline Asher, Eduardo A Lacayo, Paul L Friedlander, Robert Kutner, Ernest S Chiu

    Published 2014-01-01
    Get full text
    Article
  13. 13
    Argonaute 2 Expression Correlates with a Luminal B Breast Cancer Subtype and Induces Estrogen Receptor Alpha Isoform Variation

    Argonaute 2 Expression Correlates with a Luminal B Breast Cancer Subtype and Induces Estrogen Receptor Alpha Isoform Variation by Adrienne K. Conger, Elizabeth C. Martin, Thomas J. Yan, Lyndsay V. Rhodes, Van T. Hoang, Jacqueline La, Muralidharan Anbalagan, Hope E. Burks, Brian G. Rowan, Kenneth P. Nephew, Bridgette M. Collins-Burow, Matthew E. Burow

    Published 2016-09-01
    Get full text
    Article
  14. 14
    Annexin-A1 regulates microRNA-26b* and microRNA-562 to directly target NF-κB and angiogenesis in breast cancer cells.

    Annexin-A1 regulates microRNA-26b* and microRNA-562 to directly target NF-κB and angiogenesis in breast cancer cells. by Durkeshwari Anbalagan, Gracemary Yap, Yi Yuan, Vijay K Pandey, Wai Hoe Lau, Suruchi Arora, Pradeep Bist, Justin S B Wong, Gautam Sethi, Peter M Nissom, Peter E Lobie, Lina H K Lim

    Published 2014-01-01
    Get full text
    Article
  15. 15
    ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer

    ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer by Van T. Hoang, Margarite D. Matossian, Deniz A. Ucar, Steven Elliott, Jacqueline La, Maryl K. Wright, Hope E. Burks, Aaron Perles, Fokhrul Hossain, Connor T. King, Valentino E. Browning, Jacob Bursavich, Fang Fang, Luis Del Valle, Akshita B. Bhatt, Jane E. Cavanaugh, Patrick T. Flaherty, Muralidharan Anbalagan, Brian G. Rowan, Melyssa R. Bratton, Kenneth P. Nephew, Lucio Miele, Bridgette M. Collins-Burow, Bridgette M. Collins-Burow, Elizabeth C. Martin, Matthew E. Burow, Matthew E. Burow

    Published 2020-08-01
    Get full text
    Article
  16. 16
    A broadly neutralizing monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV-2 variants of concern.

    A broadly neutralizing monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV-2 variants of concern. by Hilal Ahmad Parray, Naveen Narayanan, Sonal Garg, Zaigham Abbas Rizvi, Tripti Shrivastava, Sachin Kushwaha, Janmejay Singh, Praveenkumar Murugavelu, Anbalagan Anantharaj, Farha Mehdi, Nisha Raj, Shivam Singh, Jyotsna Dandotiya, Asha Lukose, Deepti Jamwal, Sandeep Kumar, Adarsh K Chiranjivi, Samridhi Dhyani, Nitesh Mishra, Sanjeev Kumar, Kamini Jakhar, Sudipta Sonar, Anil Kumar Panchal, Manas Ranjan Tripathy, Shirlie Roy Chowdhury, Shubbir Ahmed, Sweety Samal, Shailendra Mani, Sankar Bhattacharyya, Supratik Das, Subrata Sinha, Kalpana Luthra, Gaurav Batra, Devinder Sehgal, Guruprasad R Medigeshi, Chandresh Sharma, Amit Awasthi, Pramod Kumar Garg, Deepak T Nair, Rajesh Kumar

    Published 2022-12-01
    Get full text
    Article

Search Tools: